Efficacy and Safety of Lenalidomide, Anti-PD-1 Antibody Combined with Orelabrutinib or Rituximab in the Treatment of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Miao Qing,Yongfen Huang, Can Chen,Lingling Wang,Jun Feng,Chuanhai Xu,Yuexin Cheng,Jianming Dong,Linlin Zhang,Hao XuBlood（2022）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
